Skip to main content
Clinical Trials/NCT03803332
NCT03803332
Recruiting
N/A

A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to Military Sexual Trauma

Weill Medical College of Cornell University1 site in 1 country208 target enrollmentMarch 9, 2020

Overview

Phase
N/A
Intervention
Exposure Therapy
Conditions
PTSD
Sponsor
Weill Medical College of Cornell University
Enrollment
208
Locations
1
Primary Endpoint
Change in CAPS-5 scores from baseline to post-treatment for the IPT treatment group
Status
Recruiting
Last Updated
16 days ago

Overview

Brief Summary

The purpose of this study is to compare two kinds of therapy for Posttraumatic Stress Disorder (PTSD): exposure therapy (ET) and Interpersonal Psychotherapy (IPT). The results of this study will allow us to see if IPT and ET are equally effective in treating PTSD due to Military Sexual Trauma, with the long-term goal of making PTSD treatment effective for as many people as possible.

Registry
clinicaltrials.gov
Start Date
March 9, 2020
End Date
September 1, 2027
Last Updated
16 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English-speaking
  • Military Sexual Trauma (MST) survivors, with MST defined as actual or threatened sexual violence, from Vietnam era to current Operation Iraqi Freedom/Operation Enduring Freedom/Operation New Dawn
  • Diagnosed with PTSD consequent to MST, with a minimum CAPS score \> 40
  • Medically stable at time of study enrollment (for persons with chronic injuries and that any disability present does not prevent attendance of weekly outpatient therapy sessions)
  • Ability to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments
  • Stable on psychotropic medication for the prior 60 days

Exclusion Criteria

  • Lifetime or current diagnosis of schizophrenia or other psychotic disorder, bipolar disorder
  • Participation in a clinical trial or concurrent evidence-based treatment for MST-related psychiatric conditions or PTSD during the previous 3 months
  • Current evidence of significant unstable medical illness or organic brain impairment such that the patient could not attend sessions regularly or complete assessments
  • Patients who in the investigator's judgment pose a current homicidal or suicidal risk
  • Current or history of substance dependence in the past 90 days.

Arms & Interventions

Exposure Therapy

Participants receive 10 90-minute exposure therapy sessions for PTSD following the treatment procedures as outlined in the standard Prolonged Exposure therapy manual.

Intervention: Exposure Therapy

Interpersonal Psychotherapy

Participants receive 14 weekly 50-minute Interpersonal Psychotherapy sessions focused on the interpersonal sequelae of trauma in current daily life.

Intervention: Interpersonal Psychotherapy

Outcomes

Primary Outcomes

Change in CAPS-5 scores from baseline to post-treatment for the IPT treatment group

Time Frame: Baseline, 15 weeks

The CAPS-5 is used for rating the severity of PTSD symptoms. Scores range from 0-80 with higher scores indicating greater PTSD severity

Difference in mean Clinician Administered PTSD Scale-5 (CAPS-5) score changes between the Exposure Therapy (ET) and Interpersonal Psychotherapy (IPT) treatment groups from baseline to post-treatment

Time Frame: Baseline, 15 weeks in the IPT condition, 11 weeks in the ET condition

The CAPS-5 is used for rating the severity of PTSD symptoms. Scores range from 0-80 with higher scores indicating greater PTSD severity

Change in CAPS-5 scores from baseline to post-treatment for the ET treatment group

Time Frame: Baseline, 11 weeks

The CAPS-5 is used for rating the severity of PTSD symptoms. Scores range from 0-80 with higher scores indicating greater PTSD severity

Study Sites (1)

Loading locations...

Similar Trials